Beximco Pharmaceuticals Ltd, also known as Beximco Pharma (stylised as BEXIMCO PHARMA) is a Bangladeshi multinational pharmaceutical company.
History
Beximco Pharma was founded in 1976 and started operations in 1980, manufacturing products under the licenses of
Bayer of Germany and
Upjohn of United States.
Today, Beximco Pharma manufactures and markets its own branded
Generic drug for several diseases including
AIDS,
cancer,
asthma,
hypertension, and
diabetes for both national and international markets. It was the first drug company from Bangladesh to sell its products in the US.
In May 2020, the company introduced the world's first generic remdesivir for COVID-19 treatment.
Factories
Beximco Pharma manufacturing facilities are spread across a site located in Dhaka, Bangladesh.
The facilities consist of a number of purpose-built plants, including a new Oral Solid Dosage (OSD) plant. The site includes manufacturing facilities as well as a research laboratory and a number of warehouses. The plant and machinery of the facilities were designed, produced and installed by partners from Germany, Switzerland, Sweden, Italy and the United Kingdom, amongst others.
Exports
In August 2007, Beximco exported its
medicines to the
Philippines, the 5th country of the 10-member Association of South East Asian Nations (
ASEAN) to
import Beximco's
drugs.
External links
